BACKGROUND: Programmed death-1 (PD1) is an immunoinhibitory receptor, and PD1 overexpression on T-cells is involved in immune evasion in cancer. This study investigated the prognostic significance of PD1 expression on T-cells in gastric cancer. MATERIALS AND METHODS: PD1 expression on CD4+ and CD8+ T-cells obtained from peripheral blood mononuclear cells was evaluated by multicolor flow cytometry. RESULTS: Based on cutoff values from receiver operating characteristic analysis, patients were sub-grouped according to PD1 positivity as having high or low PD1+CD4+ T-cell (cutoff ≥34.2%) and PD1+CD8+ T-cell (cutoff ≥28.7%) frequencies. Five-year overall survival rates differed significantly between the groups with low and high frequency of PD1+CD4+ T-cells (75.1% vs. 27.2%, respectively; p=0.0008). The 5-year overall survival rates were 78.3% and 37.2%, respectively, for the corresponding PD1+CD8+ T-cell subgroups (p=0.0004). Multivariate analysis revealed that the frequency of PD1+CD8+ T-cells was an independent prognostic indicator. CONCLUSION: The frequency of PD1+CD8+ T-cells may predict the prognosis of patients with gastric cancer. Copyright
BACKGROUND: Programmed death-1 (PD1) is an immunoinhibitory receptor, and PD1 overexpression on T-cells is involved in immune evasion in cancer. This study investigated the prognostic significance of PD1 expression on T-cells in gastric cancer. MATERIALS AND METHODS:PD1 expression on CD4+ and CD8+ T-cells obtained from peripheral blood mononuclear cells was evaluated by multicolor flow cytometry. RESULTS: Based on cutoff values from receiver operating characteristic analysis, patients were sub-grouped according to PD1 positivity as having high or low PD1+CD4+ T-cell (cutoff ≥34.2%) and PD1+CD8+ T-cell (cutoff ≥28.7%) frequencies. Five-year overall survival rates differed significantly between the groups with low and high frequency of PD1+CD4+ T-cells (75.1% vs. 27.2%, respectively; p=0.0008). The 5-year overall survival rates were 78.3% and 37.2%, respectively, for the corresponding PD1+CD8+ T-cell subgroups (p=0.0004). Multivariate analysis revealed that the frequency of PD1+CD8+ T-cells was an independent prognostic indicator. CONCLUSION: The frequency of PD1+CD8+ T-cells may predict the prognosis of patients with gastric cancer. Copyright
Authors: Katherine D Gray; Jaclyn E McCloskey; Yogindra Vedvyas; Olivia R Kalloo; Steve El Eshaky; Yanping Yang; Enda Shevlin; Marjan Zaman; Timothy M Ullmann; Heng Liang; Dessislava Stefanova; Paul J Christos; Theresa Scognamiglio; Andrew B Tassler; Rasa Zarnegar; Thomas J Fahey; Moonsoo M Jin; Irene M Min Journal: Clin Cancer Res Date: 2020-09-04 Impact factor: 12.531
Authors: Wen Juan Tu; Robert D McCuaig; Abel H Y Tan; Kristine Hardy; Nabila Seddiki; Sayed Ali; Jane E Dahlstrom; Elaine G Bean; Jenny Dunn; Jade Forwood; Sofia Tsimbalyuk; Kate Smith; Desmond Yip; Laeeq Malik; Thiru Prasanna; Peter Milburn; Sudha Rao Journal: Front Immunol Date: 2020-06-16 Impact factor: 7.561
Authors: Luka Brcic; Thomas Klikovits; Zsolt Megyesfalvi; Berta Mosleh; Katharina Sinn; Richard Hritcu; Viktoria Laszlo; Tanja Cufer; Ales Rozman; Izidor Kern; Katja Mohorcic; Marko Jakopovic; Miroslav Samarzija; Sven Seiwerth; Vitezslav Kolek; Ondřej Fischer; Petr Jakubec; Jozef Škarda; Balazs Gieszer; Balazs Hegedus; Janos Fillinger; Ferenc Renyi-Vamos; Anna Buder; Agnes Bilecz; Walter Berger; Michael Grusch; Konrad Hoetzenecker; Walter Klepetko; Mir Alireza Hoda; Martin Filipits; Balazs Dome Journal: Transl Lung Cancer Res Date: 2021-04
Authors: Clarissa F Cunha; Raquel Ferraz-Nogueira; Vanessa F A Costa; Maria Inês F Pimentel; Thaize Q Chometon; Marcelo R Lyra; Armando O Schubach; Alda Maria Da-Cruz; Alvaro Luiz Bertho Journal: PLoS One Date: 2020-03-23 Impact factor: 3.240